SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-24-019774
Filing Date
2024-11-27
Accepted
2024-11-27 17:08:40
Documents
2
Period of Report
2024-11-27

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 4074
2 B. LUU POA exhibit24-1.txt EX-24.1 3229
  Complete submission text file 0001062993-24-019774.txt   8742
Mailing Address 4 KINGSBURY AVENUE WATERTOWN MA 02472
Business Address 4 KINGSBURY AVENUE WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Issuer) CIK: 0001177648 (see all company filings)

IRS No.: 043205099 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ENANTA PHARMACEUTICALS, INC. 500 ARSENAL STREET WATERTOWN MA 02472
Business Address
Luu Brendan (Reporting) CIK: 0001842369 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35839 | Film No.: 241512322